 SAN CARLOS, Calif., Aug. 13, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the Companys management team will participate in the following upcoming investor conferences: 